1. Abshagen, U., Rennekamp, H., Kuhlmann, J.: Effects of pretreatment with spironolactone on pharmacokinetics of 4“’-methyldigoxin in man. Naunyn Schmiedebergs Arch. Pharmacol. 292, 87–92 (1976)
2. Akera, T., Brody, T.M.: The role of Nat, K+-ATPase in the inotropic action of digitalis. Pharmacol. Rev. 29, 187–220 (1978)
3. Akera, T., Temma, K., Wiest, S.A., Brody, T.M.: Reduction of the equilibrium binding of cardiac glycosides and related compounds to Na, K+-ATPase as a possible mechanism for the potassium-induced reversal of their toxicity. Naunyn Schmiedebergs Arch. Pharmacol. 304, 157–165 (1978)
4. Albert, K.S., Ayres, J.W., Di Santo, A.R., Weidler, D.J., Sakmar, E., Hallmark, M.R., Stoll, R.G., De Sante, K.A., Wagner J.G.: Influence of kaolin-pectin suspension on digoxin bioavailability. J. Pharm. Sci. 67, 1582–1586 (1978)
5. Aldous, S., McCredie, M., Thomas, R.: The absorption and metabolism of lanatoside C in man. Part 1: Comparison of oral and intravenous routes of administration. Aust. J. Pharm. Sci. NS I, 35–41 (1972)